KIDS - OrthoPediatrics Corp.
NASDAQ
->
Healthcare
->
Medical Devices
Warsaw,
United States
Type: Equity
KIDS price evolution
KIDS
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33.03 | $12.23 | $11.31 | $36.14 |
| Short term investments | $49.25 | $71.78 | $83.47 | $73.07 |
| Net receivables | $34.62 | $37.65 | $33.85 | $26.84 |
| Inventory | $105.85 | $100.53 | $90.98 | $84.92 |
| Total current assets | $226.5 | $226.17 | $223.25 | $224.98 |
| Long term investments | ||||
| Property, plant & equipment | $41.05 | $40.24 | $40.07 | $36.92 |
| Goodwill & intangible assets | $168.26 | $165.41 | $170.93 | $164.4 |
| Total noncurrent assets | $212.25 | $206.27 | $211.62 | $201.31 |
| Total investments | $49.25 | $71.78 | $83.47 | $73.07 |
| Total assets | $438.75 | $432.44 | $434.87 | $426.29 |
| Current liabilities | ||||
| Accounts payable | $12.65 | $22.59 | $20.89 | $16.69 |
| Deferred revenue | ||||
| Short long term debt | $10.3 | $10.09 | $9.86 | $8.15 |
| Total current liabilities | $41.67 | $47.93 | $44.31 | $35.22 |
| Long term debt | $13.46 | $4.14 | $4.12 | $8.94 |
| Total noncurrent liabilities | $20.05 | $10.19 | $10.25 | $17.92 |
| Total debt | $23.76 | $14.23 | $13.98 | $17.09 |
| Total liabilities | $61.72 | $58.12 | $54.56 | $53.13 |
| Shareholders' equity | ||||
| Retained earnings | -$197.74 | -$191.05 | -$186.46 | -$183.57 |
| Other shareholder equity | -$5.53 | -$12.17 | -$7.91 | -$6.05 |
| Total shareholder equity | $377.02 | $374.33 | $380.31 | $373.15 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33.03 | $8.99 | $9.01 | $30.13 |
| Short term investments | $49.25 | $109.3 | $45.9 | $55.48 |
| Net receivables | $34.62 | $24.8 | $17.94 | $17.21 |
| Inventory | $105.85 | $78.19 | $57.57 | $52.99 |
| Total current assets | $226.5 | $226.72 | $133.65 | $158.43 |
| Long term investments | ||||
| Property, plant & equipment | $41.05 | $34.29 | $28.52 | $27.23 |
| Goodwill & intangible assets | $168.26 | $166.72 | $142.11 | $134.76 |
| Total noncurrent assets | $212.25 | $201.01 | $170.63 | $161.98 |
| Total investments | $49.25 | $109.3 | $45.9 | $55.48 |
| Total assets | $438.75 | $427.73 | $304.27 | $320.41 |
| Current liabilities | ||||
| Accounts payable | $12.65 | $11.15 | $9.32 | $10.04 |
| Deferred revenue | ||||
| Short long term debt | $10.3 | $7.96 | $13 | $12.36 |
| Total current liabilities | $41.67 | $30.87 | $29.71 | $35.03 |
| Long term debt | $13.46 | $0.76 | $15.22 | $13.83 |
| Total noncurrent liabilities | $20.05 | $18.21 | $49.19 | $50.62 |
| Total debt | $23.76 | $16.74 | $28.21 | $26.19 |
| Total liabilities | $61.72 | $49.08 | $78.91 | $85.64 |
| Shareholders' equity | ||||
| Retained earnings | -$197.74 | -$176.77 | -$178.03 | -$161.77 |
| Other shareholder equity | -$5.53 | -$5.4 | $8.49 | $7.91 |
| Total shareholder equity | $377.02 | $378.65 | $225.37 | $234.77 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $37.61 | $39.97 | $39.56 | $31.59 |
| Cost of revenue | $10.9 | $9.02 | $9.53 | $8.03 |
| Gross Profit | $26.71 | $30.95 | $30.02 | $23.56 |
| Operating activities | ||||
| Research & development | $2.75 | $2.39 | $2.79 | $2.27 |
| Selling, general & administrative | $32.03 | $32.09 | $32.82 | $29.88 |
| Total operating expenses | $34.78 | $35.46 | $35.61 | $32.15 |
| Operating income | -$8.07 | -$4.51 | -$5.59 | -$8.59 |
| Income from continuing operations | ||||
| EBIT | -$7.21 | -$3.72 | -$2.99 | -$7.59 |
| Income tax expense | -$0.21 | $0.85 | -$0.4 | -$0.57 |
| Interest expense | -$0.3 | $0.02 | $0.29 | -$0.21 |
| Net income | ||||
| Net income | -$6.69 | -$4.59 | -$2.89 | -$6.81 |
| Income (for common shares) | -$6.69 | -$4.59 | -$2.89 | -$6.81 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $148.73 | $122.29 | $98.05 | $71.08 |
| Cost of revenue | $37.48 | $31.63 | $24.65 | $16.05 |
| Gross Profit | $111.25 | $90.66 | $73.4 | $55.03 |
| Operating activities | ||||
| Research & development | $10.2 | $8.01 | $5.54 | $5.27 |
| Selling, general & administrative | $126.82 | $104.44 | $85.73 | $70.17 |
| Total operating expenses | $138 | $117.86 | $90.34 | $81.77 |
| Operating income | -$26.75 | -$27.2 | -$16.94 | -$26.73 |
| Income from continuing operations | ||||
| EBIT | -$21.51 | -$1.26 | -$15.14 | -$30.25 |
| Income tax expense | -$0.34 | -$4.95 | -$1.13 | -$0.72 |
| Interest expense | -$0.2 | $2.42 | $2.25 | $3.41 |
| Net income | ||||
| Net income | -$20.97 | $1.26 | -$16.26 | -$32.94 |
| Income (for common shares) | -$20.97 | $1.26 | -$16.26 | -$32.94 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$6.69 | -$4.59 | -$2.89 | -$6.81 |
| Operating activities | ||||
| Depreciation | $5.19 | $4.27 | $4.08 | $3.85 |
| Business acquisitions & disposals | -$0.55 | -$3.1 | ||
| Stock-based compensation | $2.75 | $2.36 | $3.3 | $2.11 |
| Total cash flows from operations | -$7.54 | -$8.67 | -$4.37 | -$6.46 |
| Investing activities | ||||
| Capital expenditures | -$3.84 | -$2.48 | -$5.62 | -$4.94 |
| Investments | $23.86 | $12.69 | -$9.5 | $37.25 |
| Total cash flows from investing | $17.92 | $9.67 | -$18.22 | $32.31 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.02 | |||
| Net borrowings | $9.39 | -$0.04 | -$0.04 | -$0.04 |
| Total cash flows from financing | $9.39 | -$0.01 | -$2.04 | -$0.04 |
| Effect of exchange rate | $1.03 | -$0.06 | -$0.2 | -$0.14 |
| Change in cash and equivalents | $20.8 | $0.92 | -$24.83 | $25.68 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$20.97 | $1.26 | -$16.26 | -$32.94 |
| Operating activities | ||||
| Depreciation | $17.39 | $13.1 | $10.68 | $8.01 |
| Business acquisitions & disposals | -$3.64 | -$40.09 | -$0.65 | -$4.19 |
| Stock-based compensation | $10.53 | $6.68 | $5.84 | $6.2 |
| Total cash flows from operations | -$27.05 | -$21.77 | -$13.06 | -$18.53 |
| Investing activities | ||||
| Capital expenditures | -$16.88 | -$10.03 | -$8.1 | -$10.5 |
| Investments | $64.3 | -$63.25 | $9.25 | -$55 |
| Total cash flows from investing | $41.68 | -$113.37 | -$7.41 | -$69.69 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.02 | $139.34 | $0.14 | $71.86 |
| Net borrowings | $9.28 | -$0.14 | -$0.13 | -$25.13 |
| Total cash flows from financing | $7.3 | $135.97 | $0.01 | $46.73 |
| Effect of exchange rate | $0.63 | $0.62 | -$0.66 | -$0.4 |
| Change in cash and equivalents | $22.57 | $1.46 | -$21.13 | -$41.9 |
News
Fundamentals
| Market cap | $699.95M |
|---|---|
| Enterprise value | $690.68M |
| Shares outstanding | 23.38M |
| Revenue | $148.73M |
|---|---|
| EBITDA | -$4.13M |
| EBIT | -$21.51M |
| Net Income | -$20.97M |
| Revenue Q/Q | 21.36% |
| Revenue Y/Y | N/A |
| P/E ratio | -33.37 |
|---|---|
| EV/Sales | 4.64 |
| EV/EBITDA | -167.44 |
| EV/EBIT | -32.11 |
| P/S ratio | 4.71 |
| P/B ratio | 1.83 |
| Book/Share | 16.36 |
| Cash/Share | 1.41 |
| EPS | -$0.90 |
|---|---|
| ROA | -4.84% |
| ROE | -5.58% |
| Debt/Equity | 0.16 |
|---|---|
| Net debt/EBITDA | -6.96 |
| Current ratio | 5.44 |
| Quick ratio | 2.90 |